中国住院 COVID-19 患者当前吸烟率的系统评价：尼古丁能否成为一种治疗选择？ - Suppr

Suppr

超能文献

Systematic review of the prevalence of current smoking among hospitalized COVID‑19 patients in China: could nicotine be a therapeutic option?

作者信息

Takagi Hisato

机构信息

Shizuoka Medical Center, 762-1 Nagasawa, Shimizu-cho, Sunto-gun, Shizuoka, 411-8611, Japan.

出版信息

Intern Emerg Med. 2020 Nov;15(8):1601-1603. doi: 10.1007/s11739-020-02473-2. Epub 2020 Aug 16.

DOI:10.1007/s11739-020-02473-2

PMID:32803630

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7429138/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1324/7429138/58fd95298ad3/11739_2020_2473_Fig1_HTML.jpg

相似文献

Systematic review of the prevalence of current smoking among hospitalized COVID‑19 patients in China: could nicotine be a therapeutic option?中国住院 COVID-19 患者当前吸烟率的系统评价：尼古丁能否成为一种治疗选择？

Intern Emerg Med. 2020 Nov;15(8):1601-1603. doi: 10.1007/s11739-020-02473-2. Epub 2020 Aug 16.

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?系统评价中国住院 COVID-19 患者中当前吸烟的流行率：尼古丁是否可以成为一种治疗选择？

Intern Emerg Med. 2020 Aug;15(5):845-852. doi: 10.1007/s11739-020-02355-7. Epub 2020 May 9.

COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine.新型冠状病毒肺炎：吸烟流行率的反直觉数据及尼古丁的治疗意义

Intern Emerg Med. 2020 Aug;15(5):853-856. doi: 10.1007/s11739-020-02361-9. Epub 2020 May 19.

COVID-19 and smoking: is nicotine the hidden link?新型冠状病毒肺炎与吸烟：尼古丁是隐藏的关联吗？

Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.01116-2020. Print 2020 Jun.

[COVID-19 and changes in smoking behavior].[新型冠状病毒肺炎与吸烟行为的变化]

Rev Mal Respir. 2020 Oct;37(8):684-686. doi: 10.1016/j.rmr.2020.08.004. Epub 2020 Aug 24.

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment.对中国住院 COVID-19 患者当前吸烟流行率的系统评价：尼古丁是否可以成为一种治疗选择？：评论。

Intern Emerg Med. 2021 Jan;16(1):233-234. doi: 10.1007/s11739-020-02396-y. Epub 2020 Jun 8.

Beyond Smoking Cessation: Investigating Medicinal Nicotine to Prevent and Treat COVID-19.超越戒烟：研究药用尼古丁预防和治疗新冠病毒疾病

Nicotine Tob Res. 2020 Aug 24;22(9):1669-1670. doi: 10.1093/ntr/ntaa077.

Does active smoking worsen Covid-19?主动吸烟会使新冠肺炎恶化吗？

Eur J Intern Med. 2020 Jul;77:129-131. doi: 10.1016/j.ejim.2020.05.038. Epub 2020 May 28.

Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China.中国无症状旅行者引发的大规模新冠病毒疫情。

Emerg Infect Dis. 2020 Dec;26(12):3106. doi: 10.3201/eid2612.203437.

Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.住院的新冠肺炎患者与静脉血栓栓塞：一场完美风暴。

Circulation. 2020 Jul 14;142(2):129-132. doi: 10.1161/CIRCULATIONAHA.120.048020. Epub 2020 Jul 13.

引用本文的文献

Effects on Health of Passive Smoking and Vape on Terraces in the COVID-19 Pandemic: A Review.新冠疫情期间露台被动吸烟和吸电子烟对健康的影响：综述

Open Respir Arch. 2022 Sep 13;4(4):100204. doi: 10.1016/j.opresp.2022.100204. eCollection 2022 Oct-Dec.

Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.COVID-19 感染对既往呼吸道疾病的短期和长期影响。

Arch Bronconeumol. 2022 Apr;58 Suppl 1:39-50. doi: 10.1016/j.arbres.2022.03.011. Epub 2022 Apr 15.

[Reply to "Smoker, Former Smoker and COVID-19"].[对《吸烟者、既往吸烟者与2019冠状病毒病》的回复]

Arch Bronconeumol. 2021 Apr;57:67-68. doi: 10.1016/j.arbres.2021.01.005. Epub 2021 Jan 25.

Psychotropics and COVID-19: An analysis of safety and prophylaxis.精神药物与 COVID-19：安全性与预防分析。

Encephale. 2021 Dec;47(6):564-588. doi: 10.1016/j.encep.2021.08.002. Epub 2021 Sep 2.

A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19.系统评价和荟萃分析住院吸烟者与 COVID-19 。

Int J Environ Res Public Health. 2020 Oct 11;17(20):7394. doi: 10.3390/ijerph17207394.

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply.对中国新冠肺炎住院患者当前吸烟率的系统评价：尼古丁能否成为一种治疗选择？回复。

Intern Emerg Med. 2021 Jan;16(1):235-236. doi: 10.1007/s11739-020-02457-2. Epub 2020 Sep 21.

本文引用的文献

COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine.新型冠状病毒肺炎：吸烟流行率的反直觉数据及尼古丁的治疗意义

Intern Emerg Med. 2020 Aug;15(5):853-856. doi: 10.1007/s11739-020-02361-9. Epub 2020 May 19.

Intern Emerg Med. 2020 Aug;15(5):845-852. doi: 10.1007/s11739-020-02355-7. Epub 2020 May 9.

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素：系统文献回顾和荟萃分析。

J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.

The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.COPD 和吸烟史对 COVID-19 严重程度的影响：系统评价和荟萃分析。

J Med Virol. 2020 Oct;92(10):1915-1921. doi: 10.1002/jmv.25889. Epub 2020 May 17.

Nicotine and the renin-angiotensin system.尼古丁与肾素-血管紧张素系统。

Am J Physiol Regul Integr Comp Physiol. 2018 Nov 1;315(5):R895-R906. doi: 10.1152/ajpregu.00099.2018. Epub 2018 Aug 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验